Trust Company of Vermont’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Trust Company of Vermont’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-779	Closed	-$42K	–	1014
2017 Q4	$42K	Sell	779 -25	-3%	-$1.37K	﹤0.01%	545
2017 Q3	$46K	Hold	804	–	–	﹤0.01%	511
2017 Q2	$48K	Sell	804 -387	-32%	-$22K	﹤0.01%	508
2017 Q1	$65K	Buy	+1,191	New	+$58.7K	0.01%	452

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Trust Company of Vermont's BIVV Position: Q1 2018 in Review

Trust Company of Vermont sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 779 shares — an estimated $42K sold.

Trust Company of Vermont first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $65K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Trust Company of Vermont reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Trust Company of Vermont sold 779 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $42K.
Trust Company of Vermont first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Trust Company of Vermont's Bioverativ Inc. Common Stock position peaked at $65K in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Trust Company of Vermont's 13F filing for Q1 2018, filed 18 May 2018.